3) should be strongly encouraged over technical outcomes such as lytic success and surrogate
markers such as reflux and residual venous obstruction.
Randomized clinical trials, including the ATTRACT104
(Acute Venous Thrombosis: Thrombus Removal with
Adjunctive Catheter-Directed Thrombolysis) and
CaVenT50,105 (Catheter-directed Venous Thrombolysis
in Acute Iliofemoral Ve